Sales and Marketing

Showing 15 posts of 11527 posts found.

A revolution for the NHS – an opportunity for pharma?

August 9, 2010 Sales and Marketing GlaxoSmithKline, NHS

Healthcare systems across western Europe are currently under renewed pressure and scrutiny, each government preoccupied with finding major cost-savings to …

NICE: the end of an era

August 9, 2010 Sales and Marketing Andrew Lansley, NICE, VBP, government

NICE is undergoing a momentus shift in its role which will see it leave behind the frequent clashes and controversy …

MSD launches asthma training resources

August 6, 2010 Medical Communications, Sales and Marketing MSD, asthma, medical education, merck sharp and dohme, nurses

A new training resource aimed at helping primary care nurses manage asthma has been launched with funding from Merck Sharp …

Shire profits from Genzyme woes

August 5, 2010 Sales and Marketing Shire

Specialist pharma company Shire has posted a set of strong results, thanks in part to the gains it has made …

Health Professions Council appoints Doctors.net.uk

August 5, 2010 Sales and Marketing BMA, Doctors.net.uk, GMC, HPC, Lansley

Established to regulate fifteen different health professions, including groups as diverse as paramedics, physiotherapists, practitioner psychologists, clinical scientists, podiatrists/chiropodists and …

Pharma Commitment to e-Marketing Grows

August 5, 2010 Sales and Marketing BMA, GMC, Lansley, digital, doctors, electronic marketing, marketing

A survey of pharma marketers has revealed growing commitment to e-marketing with online spend on the increase across the sector.  …

Doctors.net.uk Strengthens Pharmaceutical Team

August 5, 2010 Sales and Marketing Doctors.net.uk, GPs, doctors, marketing, medeconnect, pharma, sales

Doctors.net.uk, the UK’s largest and most active online network of healthcare professionals, has strengthened its pharmaceutical team with two appointments.  …

Generic clopidogrel helps NICE recommend blood clot prevention

August 5, 2010 Sales and Marketing NICE, Plavix

NICE has given preliminary approval for wider use of Sanofi-Aventis’s Plavix and Boehringer Ingelheim’s Persantine to prevent blood clots. It …

Shire moves in on Movetis

August 5, 2010 Research and Development, Sales and Marketing Movetis, Shire

Shire has made a €428 million offer for Belgium-based Movetis in a bid to grow its business in Europe and …

Austerity measures beginning to bite in Europe

August 5, 2010 Sales and Marketing Europe, economic climate, global pricing, price cuts

Major pharmaceutical companies are beginning to feel the direct effects of the austerity measures being introduced across Europe’s healthcare systems.Second …

NICE set to recommend chronic constipation treatment

August 4, 2010 Sales and Marketing Movetis, NICE, Resolor

NICE has provisionally recommended Belgium-based Movetis’s Resolor as an option for the treatment of chronic constipation in women where laxatives …

Wyeth acquisition boosts Pfizer results

August 4, 2010 Sales and Marketing 2010 financials, Pfizer, Q2

Pfizer’s second quarter results received a huge boost from the company’s multi-billion dollar acquisition of Wyeth last October. Sales of …

Sanofi appoints Dr Ian Weatherhead UK coms director

August 4, 2010 Medical Communications, Research and Development, Sales and Marketing Sanofi-Aventis, UK, appointment, research and development, sales and marketing

Sanofi-Aventis UK has appointed Dr Ian Weatherhead as its director of communications. Ian will join the Guildford-based company in October, …

New products help lift UCB

August 3, 2010 Sales and Marketing 2010 financials, Q2, UCB

UCB’s newer products showed impressive growth in the first six months of this year, helping keep the Belgium-based biopharma firm’s …
The Gateway to Local Adoption Series

Latest content